Journal
DALTON TRANSACTIONS
Volume 39, Issue 3, Pages 704-706Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/b919119b
Keywords
-
Categories
Funding
- FFG (Austrian Research Promotion Agency) [811591]
- Austrian Council for Research and Technology Development
Ask authors/readers for more resources
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone), which entered several phase I and II clinical trials as an antitumor chemotherapeutic agent, was found to possess intrinsic fluorescence properties (lambda(ex) = 360 nm), which enabled us to monitor the uptake and intracellular distribution in living human cancer cells by fluorescence microscopy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
